Related Experiment Videos
[NF-kappa B and prostatic adenocarcinoma]
Song-Tao Xiang1, Hui Guo, Si-Wei Zhou
1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Zhonghua Nan Ke Xue = National Journal of Andrology
|November 25, 2003
Summary
Nuclear factor of kappa B (NF-kappa B) regulates genes in immunity, apoptosis, and cancer. Targeting NF-kappa B shows promise for gene therapy in treating prostatic adenocarcinoma metastasis and drug resistance.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Context:
- Nuclear factor of kappa B (NF-kappa B) is a critical transcription factor involved in cellular processes.
- NF-kappa B plays a significant role in inflammation, apoptosis, and neoplasia.
- Recent research highlights NF-kappa B's involvement in cancer progression, including metastasis and drug resistance.
Purpose:
- To review recent advancements in understanding the structure and function of NF-kappa B.
- To explore the relationship between NF-kappa B and the infiltration and metastasis of prostatic adenocarcinoma.
- To discuss the potential of NF-kappa B as a target for gene therapy in cancer treatment.
Summary:
- NF-kappa B is a key transcription factor regulating genes involved in immunity, apoptosis, inflammation, and cancer.
- Its role in neoplasia, infiltration, metastasis, and drug resistance makes it a significant area of research.
- NF-kappa B presents a promising molecular target for developing novel gene therapy strategies.
Impact:
- Understanding NF-kappa B's function can lead to new therapeutic strategies for cancer.
- Targeting NF-kappa B may offer a pathway for effective gene therapy in treating prostatic adenocarcinoma.
- This review consolidates current knowledge, guiding future research in NF-kappa B and cancer therapeutics.